Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection

NCT04675086 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Administrative Decision

Conditions

Covid19
Pneumonia, Viral

Interventions

DRUG: alpha1-proteinase inhibitor
DRUG: Antiviral Agents

Sponsor

Blessing Corporate Services, Inc

Collaborators

[object Object]